Leading the Way in Life Science Technologies

GEN Exclusives

More »

Sequencing - Related Content

  • Page 1 of 1 (3 items) 1 
  • GEN Podcasts
  • NANOTECHNOLOGISTS CREATE ARTIFICIAL PORE
    - Interview with Peixuan Guo, Ph.D., Director of the NIH Nanomedicine Development Center at the University of Cincinnati, Endowed Chair, and Professor of Biomedical Engineering
  • ALUMINUM OXIDE NANOPORE FOR DNA ANALYSIS
    - Interview with Bala Murali Venkatesan, Fourth-Year Graduate Student, Department of Electrical and Computer Engineering Department, University of Illinois at Urbana-Champaign
  • Richard A. Gibbs, Ph.D.
    - from the Baylor College of Medicine, talks with GEN's Editor-in-Chief John Sterling about frontiers in DNA sequencing.
  • Page 1 of 1 (3 items) 1 

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »